PL:NYSEPlanet Labs PBC Analysis
Data as of 2026-09-04 - not real-time
$18.35
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Planet Labs PBC trades at $18.35, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 17.9%. Momentum indicators put RSI at 29.3 (oversold) with MACD reading bearish. Price has been bracketed by support at $17.83 and resistance at $25.53.
The shares look overvalued, trading on 1835.0 times earnings above a sector average of 28.3. The average analyst target implies 111.0% above today's level. Revenue is growing at 42.1% on a -111.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 60.5%, a beta of 2.49 and a maximum drawdown of 64.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
The shares look overvalued, trading on 1835.0 times earnings above a sector average of 28.3. The average analyst target implies 111.0% above today's level. Revenue is growing at 42.1% on a -111.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 60.5%, a beta of 2.49 and a maximum drawdown of 64.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
Top Market Events
Both companies are unprofitable but growing rapidly, though one carries significantly lower valuation multiples and...Planet Labs PL stock wins 7-figure European defense contract.One trades at 21.9x forward earnings with $8.6B in free cash flow; the other with persistent losses and satellite risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.3 signals oversold conditions
- Trading below the 200-day average of 26.94
Medium Term
1–3 yearsCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.3 signals oversold conditions
- P/E of 1835.0 versus sector average of 28.3
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E of 1835.0 versus sector average of 28.3
- Negative profit margin of -111.2%
- Analyst targets imply +111.0% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth42.10%
Profit Margin-111.17%
P/E Ratio1835.0
ROE-83.98%
ROA-5.87%
Debt/Equity109.99
P/B Ratio14.7
Op. Cash Flow$132.5M
Free Cash Flow$84.9M
Industry P/E28.3
Technical Analysis
TrendBearish
RSI29.3
Support$17.83
Resistance$25.53
MA 20$22.12
MA 50$23.73
MA 200$26.94
MACDBearish
VolumeIncreasing
Fear & Greed Index96.14
Valuation
Fair Value$8.87
Target Price$38.73
Upside/Downside111.05%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.49
Volatility60.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.